H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Census population 675,647. Massachusetts Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Boston clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Boston storefront.
Chronic Wound Treatment That Works in Boston, MA for clinics & physicians. Effective chronic wound treatme… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of chronic wound treatment in Boston: (1) CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. (2) Massachusetts Part B wound biologics are reviewed by National Government Services (NGS) under JK, shared with CT, ME, NH, NY, RI, VT. We help with the second file. We do not pretend to be a Boston storefront.
National Chronic Wound Treatment That Works notes (how the product actually works)Massachusetts shares JK with CT, ME, NH, NY, RI, VT. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the chronic wound treatment account.
CDC PLACES (2023, crude prevalence) estimates 8.6% of adults — 3.4 points below the U.S. 12% figure. Obesity is 23.4%; arthritis is 17.8%. That is place-level BRFSS modeling, not a clinic census and not a Boston trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Massachusetts compliance risk.
It is the Census city-proper count — useful as scale for a city of 500k–1M. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
Hawk Medical works with independent reps who already have physician call points. Territory conversations start at /become-a-rep — not by scraping this city URL.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Boston, MA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Boston is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Boston — 3.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Massachusetts Part B wound biologics follow this contractor (siblings: CT, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Boston. Useful for joint-program math; still needs a diagnosis and privileging.
No Boston storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.